4D Medical
Improving global health by providing unique and non-invasive imaging technologies that enable unprecedented insight into pulmonary functioning, critical in the analysis and management of respiratory diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | AUD40.0m | Post IPO Equity |
| Total Funding | 000k | ||
Related Content
4DMedical is a pioneering company in the field of lung health, offering advanced imaging technology that captures the motion of the lungs to provide detailed insights into lung function. This innovative approach allows for a more accurate diagnosis and treatment of lung conditions, benefiting patients globally. The company primarily serves healthcare providers, including hospitals and clinics, and operates in the medical imaging market. 4DMedical's business model revolves around selling its imaging technology and related services to these healthcare institutions. Revenue is generated through the sale of imaging systems, software licenses, and ongoing service agreements. By focusing on improving the speed and accuracy of lung health assessments, 4DMedical aims to revolutionize the way lung diseases are diagnosed and treated, ultimately enhancing patient outcomes.
Keywords: lung imaging, healthcare, diagnostics, lung function, medical technology, patient outcomes, imaging systems, software licenses, healthcare providers, medical innovation.